Wednesday, April 7, 2010 as of 11:14 AM ET
Smith & Nephew plc () is a global medical devices company headquartered in London, United Kingdom. It is the world's largest producer of arthroscopy products, second-largest producer of advanced wound management products, third-largest producer of trauma and clinical therapy products and fourth-largest producer of orthopedic reconstruction products.
Read More at Wikipedia ›U.
K. medical device maker Smith & Nephew PLC (SN.LN) Thursday reported a 3% rise in first-quarter net profit and said that guidance for the full year, provided last quarter, is unchanged.Chief Executive Olivier Bohuon said: "We grew revenue, increased profit and improved our trading profit margin. We saw the first results of our actions to make Smith & Nephew more fit and effective."Net profit rose to $161 million from $156 million a year earlier. Revenue was flat at $1.08 billion, in line with expectations. Earnings per share, excluding some items, rose to 19.5 cents from 18.4 cents, ahead of analysts' average expectations.No dividends were paid during the first quarters of 2012 or 2011.U.S. rival Zimmer's (ZMH) first-quarter results last month showed continued weakness in the market for replacement hip and knees, hurt by the ongoing economic slowdown as patients, reluctant to take time off work, postponed procedures.Still, there are indications the declines could be moderating.U.S. r...By Katie ReidZURICH (Reuters) - Synthes <SYST.VX> said on Monday it was in takeover talks with Johnson & Johnson <JNJ.N>, after reports the U.S. group is looking to ...
FOX Business: The Power to ProsperBuilding on its first seven-week surge in nearly four years, Wall Street climbed steadily higher to fresh two-year highs on Tuesday...
LONDON (MarketWatch) -- The U.K.'s benchmark index ended with a small loss Monday, with weak banking shares offsetting deal news in the medical-devices industry.The ...
LONDON (MarketWatch) -- The U.K.'s benchmark index held steady Monday as gains for oil giant BP PLC and deal news in the medical-devices industry were offset by loss...
LONDON -(Dow Jones)- Shares in U.K.-based Smith & Nephew PLC (SN.LN) jumped 4% in early business Monday after the Sunday Times newspaper reported that U.S. pharmaceu...
LONDON (MarketWatch) -- London's benchmark stock index ended lower Friday, weighed down by losses across the mining sector, while shares of technology firm ARM Holdi...
LONDON (MarketWatch) -- London's benchmark stock index declined on Friday, weighed down by the mining sector, while shares of technology firm ARM Holdings PLC rallie...
LONDON -(Dow Jones)- U.K.-based Smith & Nephew PLC (SN.LN) took the unusual step Friday of denying it was in any takeover talks after market speculation pushed share...
LONDON -(Dow Jones)- Smith & Nephew PLC (SN.LN), a global medical technology business, said Friday it is not engaged in any discussions which could lead to a merger ...
TIDMSN.RNS Number : 4884ZSmith & Nephew Plc14 January 2011NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE ...
LONDON -- Medical-device firm Smith & Nephew PLC said Friday it's not involved in talks that could result in a merger or a takeover of the company. The statement fol...
Here are stocks that are up on high volume:Today, Universal Display Corporation (NASDAQ:PANL) is up on high volume, trading at a volume of 1.1 million, or 1.9 times ...
Here are stocks that are down on high volume today:Trading at a volume of five million, or 2.1 times its average daily volume, Google (NASDAQ:GOOG) is down on high v...
DOW JONES NEWSWIRESMedical-device company Biomet Inc. has agreed to pay about $23 million to settle civil and criminal charges stemming from allegations the company'...
DOW JONES NEWSWIRESMedical-device company Biomet Inc. has agreed to pay about $22.7 million to settle civil and criminal charges stemming from allegations the compan...
The Securities and Exchange Commission on Monday charged medical device company Smith & Nephew under the Foreign Corrupt Practices Act for bribing Greek public docto...
--Replacement-joint sales remain soft, similar to prior fiscal quarter-- Biomet CEO cites volume and pricing pressure on industry, and says company isn't growing fas...
--Replacement joint sales remain soft, similar to prior fiscal quarter-- Biomet CEO cites volume and pricing pressure on industry, and says company isn't growing fas...
